Cyclobarbital, also known as cyclobarbitol or cyclobarbitone, is a barbiturate derivative.[2] It was available in Russia as a fixed-dose combination with diazepam (100 mg cyclobarbital + 10 mg diazepam; brand name Reladorm) for the treatment of insomnia but was discontinued in 2019.
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral (tablets) |
ATC code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.000.127 |
Chemical and physical data | |
Formula | C12H16N2O3 |
Molar mass | 236.271 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(what is this?) (verify) |